Description

Methanone, (3-Ethyl-5-Methyl-4-Isoxazolyl)[4-[3-(Trifluoromethyl)Phenyl]-1-Piperazinyl]- is a high-purity, advanced pharmaceutical intermediate characterized by its unique heterocyclic structure incorporating an isoxazole and a piperazine moiety. This compound is of significant commercial interest for its role as a key building block in the research and development of novel active pharmaceutical ingredients (APIs), particularly in central nervous system (CNS) and other therapeutic areas. It is primarily targeted at pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers seeking reliable, high-quality intermediates for complex synthesis.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of potential drug candidates, especially those targeting neurological receptors.
• Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and the discovery of new bioactive molecules.
• Chemical Synthesis: Serves as a versatile building block for constructing complex heterocyclic frameworks in organic chemistry.
• Reference Standard: Employed as an analytical standard in quality control laboratories for method development and validation.
• Preclinical Studies: Supplied for use in early-stage pharmacological and toxicological evaluations of new chemical entities.

Basic Information

Product Name	Methanone, (3-Ethyl-5-Methyl-4-Isoxazolyl)[4-[3-(Trifluoromethyl)Phenyl]-1-Piperazinyl]-
CAS No.	932854-69-8
Molecular Formula	C18H20F3N3O2
Molecular Weight	367.37 g/mol
Synonyms	(3-Ethyl-5-methyl-4-isoxazolyl){4-[3-(trifluoromethyl)phenyl]-1-piperazinyl}methanone; 1-[3-(Trifluoromethyl)phenyl]-4-[(3-ethyl-5-methyl-4-isoxazolyl)carbonyl]piperazine; 4-[3-(Trifluoromethyl)phenyl]-1-[(3-ethyl-5-methyl-4-isoxazolyl)carbonyl]piperazine; (3-Ethyl-5-methylisoxazol-4-yl)(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)methanone; CAS 932854-69-8
EINECS	Contact for details

Quality Control

Our Methanone, (3-Ethyl-5-Methyl-4-Isoxazolyl)[4-[3-(Trifluoromethyl)Phenyl]-1-Piperazinyl]- is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing all test results is provided with every shipment to guarantee traceability and compliance with your specifications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive); the container must be kept tightly sealed to prevent degradation from atmospheric moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.